Habitual short sleep duration and circulating endothelial progenitor cells by Weil, Brian R. et al.
110 Journal of Cardiovascular Disease Research Vol. 2 / No 2
ABSTRACT
Chronic short sleep duration has been linked to endothelial dysfunction and increased risk of cardiovascular 
disease. Circulating endothelial progenitor cells (EPCs) are vital to endogenous vascular repair processes and 
cardiovascular health. We tested the hypothesis that habitual short sleep duration is associated with impairment 
in EPC number and function. Cells with phenotypic EPC characteristics were isolated from 37 healthy, sedentary 
adults: 20 with normal sleep duration (13M/7F; age: 59±1 years; sleep duration: 7.7±0.1 h/night) and 17 with short 
sleep duration (9M/8F; 56±2 years; 6.0±0.2 h/night). EPC number was assessed by flow cytometric analysis of 
the percentage of peripheral blood mononuclear cells negative for CD45 and positive for CD34, VEGFR-2, and 
CD133 antigens. EPC colony-forming capacity was determined by colony-forming unit (CFU) assay; migration 
by Boyden chamber; and intracellular caspase-3 concentrations by immunoassay. There were no significant 
differences between groups in EPC number (0.001±0.0004 vs. 0.001±0.0003 %), colony-forming capacity 
(6.1±1.5 vs. 5.4±1.7 CFUs), or migration to VEGF (1410.1±151.2 vs. 1334.3±111.1 AU). Furthermore, there 
were no group differences in basal and staurosporine-stimulated intracellular concentrations of active caspase-3 
(0.3±0.03 vs. 0.5±0.1 ng/mL; and 2.9±0.4 vs. 2.7±0.3 ng/mL), a marker of apoptotic susceptibility. Taken 
together, these data indicate that short sleep duration is not associated with EPC dysfunction in healthy adults. 
Numerical and functional impairment in circulating EPCs may not contribute to the increased cardiovascular 
risk with habitual short sleep duration.
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INTRODUCTION
It has become increasingly apparent that chronic short 
sleep duration adversely affects cardiovascular health. 
Several recent epidemiological studies have reported 
that short sleep duration is associated with increased 
cardiovascular morbidity and mortality.[1] However, the 
biological mechanisms linking habitual short sleep duration 
and the development of cardiovascular diseases (CVDs) 
are not well-defined.
Endothelial damage and dysfunction is an important early 
event in the pathogenesis of atherosclerotic vascular disease 
and is independently associated with an increased risk of 
cardiovascular events.[2] Recent data from our laboratory[3] 
and others[4] suggest that acute and chronic sleep restriction 
is associated with pathogenic alterations in endothelial cell 
function. The capacity to repair the endothelium and restore 
its function after injury also plays a vital role in determining 
cardiovascular risk.[5] Circulating endothelial progenitor 
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cells (EPCs) have recently been identified as an integral 
component of the endogenous vascular repair system.[5] 
Importantly, declines in both EPC number and function 
have been linked with accelerated atherosclerotic disease 
progression and poor CVD prognosis.[6-8] Thus, a potential 
mechanism contributing to the heightened cardiovascular 
risk with short sleep duration may be a reduction in EPC 
bioavailability and/or function. Accordingly, we tested the 
hypothesis that habitual short sleep duration is associated 
with impairment in EPC number and function.
MATERIALS AND METHODS
Subjects
Thirty-seven adults (age range: 43–65 years) were studied: 20 
with normal habitual sleep duration (13 males/7 females) and 
17 with short habitual sleep duration (9 males/8 females). 
All subjects were free of overt cardiometabolic disease as 
assessed by medical history, physical examination, and fasting 
blood chemistries. All female subjects were at least one year 
postmenopausal and had never taken or had discontinued 
use of hormone replacement therapy at least one year prior 
to the start of the study. None of the subjects smoked, were 
taking medications, or performed regular physical exercise 
for at least 6 months before the start of the study. Prior to 
participation, all of the subjects had the research study and its 
potential risks and benefits explained fully before providing 
written informed consent according to the guidelines of the 
University of Colorado at Boulder.
Sleep duration
Habitual sleep duration was measured as a component of 
the Stanford Physical Activity Questionnaire, as previously 
described.[3] Consistent with previous studies,[9] nightly 
average reported sleep duration was calculated as the 
weighted average of weeknights and weekend values [(5 × 
weekday sleep duration) + (2 × weekend sleep duration)/7]. 
Subjects were divided into two groups based upon their 
reported sleep duration: 7 to 9 h/night or “normal habitual 
sleep duration” and <7 h/night or “short habitual sleep 
duration”. These criteria were chosen based on published 
reports indicating that habitual sleep duration shorter 
than 7 h/night is associated with increased health risks, 
including hypertension, coronary artery disease, and 
stroke.[1] Although assessment of habitual sleep duration 
by self-report has the potential to introduce reporting 
bias and experimental error, previous investigations have 
demonstrated a robust correlation between self-reported 
sleep duration and that measured objectively through 
actigraphic monitoring.[10]
Body composition and metabolic measurements
Body mass was measured to the nearest 0.1 kg using a 
medical beam balance. Percent body fat was determined 
by dual-energy X-ray absorptiometry (Lunar, Madison, 
WI). Body mass index was calculated as mass (kilograms) 
divided by height (meters) squared. Fasting plasma lipid 
and lipoprotein, glucose, and insulin concentrations were 
determined using conventional methods by the clinical 
laboratory affiliated with the University of Colorado at 
Boulder Clinical and Translational Research Center.
EPC isolation, characterization, and numeration
Circulating putative EPCs were isolated from peripheral 
blood by Ficoll density–gradient centrifugation (Histopaque 
1077, Sigma Aldrich, St Louis, MO, USA) as previously 
described by our laboratory.[11] Circulating EPC number was 
determined by fluorescence-activated cell sorting (FACS) 
analysis. Briefly, 2 × 106 cells were incubated at 4°C for 
30 min with monoclonal antibodies for PC7-conjugated 
CD45 (Beckman Coulter, Fullerton, CA, USA), FITC-
conjugated CD34 (Beckman Coulter), PE-conjugated 
VEGFR-2 (R&D Systems, Minneapolis, MN, USA) and 
APC-conjugated CD133 (Miltenyi Biotech, Auburn, CA, 
USA). Cells were gated for low expression of CD45 and 
then CD34+ cells were analyzed for events double-positive 
for VEGFR-2 and CD133 and presented as a percent of 
total viable mononuclear cells.
Colony-forming assay
EPC colony-forming capacity was determined as previously 
described.[11] Briefly, freshly isolated mononuclear cells were 
plated on six-well plates coated with human fibronectin (BD 
Biosciences, San Jose, CA, USA) for 48 h at 37ºC. Thereafter, 
non-adherent cells were collected and 5 × 105 cells were 
replated onto 24-well fibronectin-coated plates (BD 
Biosciences). Growth medium was changed every three days, 
and the EPC colony-forming units (CFUs) were counted 
manually in four random wells on the seventh day by two 
independent investigators blinded to sample identification.
Migration assay 
EPC migratory capacity was measured using a modified 
Boyden chamber.[12] Non-adherent cells (4 × 105) were 
resuspended in serum-free culture medium (Medium 199, 
GIBCO) and loaded in the upper compartment of a 24-
well modified Boyden chamber coated with fibronectin 
(FluoroBlok, BD Biosciences). The upper chamber was 
placed in the lower chamber containing culture medium 112 Journal of Cardiovascular Disease Research Vol. 2 / No 2
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supplemented with vascular endothelial growth factor 
(2 ng/ml) and incubated for 22 h at 37°C. Following 
incubation, cells were labeled with calcein AM (Molecular 
Probes, Eugene, Oregon), and relative fluorescent units 
(RFUs) of migrated cells were determined in triplicate. 
Caspase-3 activation
Activation of caspase-3 was induced by incubating EPCs 
with staurosporine (1 μmol/L) for 3 h; Sigma Aldrich, St. 
Louis, MO). Following staurosporine stimulation, cells 
were washed with PBS and incubated with 10 mmol biotin-
ZVKD-fmk inhibitor for 1 h at 37°C. Thereafter, cells were 
washed and lysed with extraction buffer at a concentration 
of 1 × 107 cells/mL. The concentration of active caspase-3 
in the supernatant was determined by enzyme immunoassay 
(R&D Systems, Minneapolis, MN). 
Statistical analysis
Differences in subject baseline characteristics and the 
primary outcome variables were determined by analysis 
of variance (ANOVA). There were no significant gender 
interactions in any of the primary outcome variables; 
therefore, the data were pooled and presented together. 
Relations between sleep duration and EPC measures were 
assessed by linear regression analysis. Data are reported as 
mean ± SEM. Statistical significance was set at P<0.05. 
RESULTS
Selected subject characteristics are presented in Table 1. 
Anthropometric characteristics were similar between the 
groups. The short sleep duration group reported a 
significantly lower average sleep duration (6.0 ± 0.2 h/night; 
range: 4.0 to 6.9 h/night) compared with the normal sleep 
duration group (7.7 ± 0.1 h/night; range: 7.0 to 9.0 h/night). 
There were no differences between the groups in plasma 
lipid and lipoprotein, glucose, and insulin concentrations.
The number of CD45-/CD34+/VEGFR-2+/CD133+ cells 
was not different between the normal sleep (0.0011 ± 0.0003%) 
and short sleep duration (0.0014 ± 0.0004%) groups. There 
were no significant differences in the number of EPC CFUs 
between the normal sleep (6 ± 2) and short sleep duration 
(5 ± 2) groups [Figure 1]. EPC migratory activity was similar 
between adults reporting normal sleep duration (1410 ± 151 
RFU) and adults reporting short sleep duration (1334 ± 111 
RFU; Figure 1). Under basal conditions, there was no 
difference in intracellular active caspase-3 concentrations 
between the normal sleep (0.3 ± 0.03 ng/mL) and short sleep 
(0.4 ± 0.11 ng/mL) duration groups. Following treatment 
with the pro-apoptotic stimulus staurosporine, intracellular 
caspase-3 concentrations significantly increased in both 
groups. However, there was no significant difference in 
stimulated intracellular caspase-3 concentrations between 
the normal sleep duration (2.8 ± 0.3 ng/mL) and short sleep 
(2.7 ± 0.3 ng/mL) groups [Figure 1]. There were no significant 
correlations between sleep duration and any EPC measure.
Figure 1: EPC colony-forming units (a), migratory activity (b), and 
intracellular concentrations of active caspase-3 under basal conditions 
and in response to staurosporine (c) in the normal sleep and short sleep 
duration groups. Values are mean ± SEM
a
b
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DISCUSSION
The primary new findings of the present study are that 
EPC number, capacity to form colonies, migratory ability, 
and apoptotic susceptibility are not impaired in healthy 
adults who sleep less than 7 h/night. Collectively, these data 
suggest that a decrement in EPC number or function is 
not involved in the increased cardiovascular risk observed 
in this population.
Endothelial dysfunction has recently been identified as a 
potential link between short sleep duration and CVD.[3,4] 
Maintenance and repair of the endothelium is essential 
in preserving function and preventing the development 
and progression of atherosclerotic disease. EPCs play an 
important role in vascular repair and can promote both re-
endothelialization and neovascularization.[5] Several studies 
have linked reduced number and function of circulating 
EPCs to endothelial dysfunction and CVD risk.[6-8] For 
example, Schmidt-Lucke and colleagues reported that 
lower number of circulating EPCs independently predicts 
atherosclerotic disease progression.[6] Moreover, reduced 
EPC colony-forming capacity and migratory ability have 
each been independently linked to an increased risk of 
CVD,[7,8] while heightened EPC susceptibility to apoptosis 
can underlie functional impairments and contribute to 
endothelial dysfunction and atherogenesis.[5]
In the present study, contrary to our hypothesis, habitual 
short sleep duration was not associated with impairments 
in EPC number or function. Circulating numbers of 
EPCs as well as their ability to form colonies, migrate and 
resist apoptosis was almost identical between middle-aged 
adults who chronically sleep ~6 h/night compared with 
those who sleep ~8 h/night. Although we observed no 
significant relation between sleep duration and any of the 
EPC measures, we studied a subpopulation (n=7) of adults 
within the short sleep duration group who reported ≤5 h 
of sleep per night to dismiss the possibility that the mean 
habitual sleep duration was not low enough in the short sleep 
group to induce EPC abnormalities. Similar to our findings 
in the overall study population, EPC number and functional 
characteristics were not different in the subpopulation with 
shorter chronic sleep duration compared with the normal 
sleep group. However, it remains possible that more severe 
chronic sleep restriction is associated with impairments in 
EPC number and/or function. This notion is supported 
by data indicating that ten days of severe sleep restriction 
(<4 h/night) elicits increased production of inflammatory 
mediators that have been shown to attenuate EPC survival, 
differentiation, and function.[13-15]
To our knowledge, this is the first study to examine 
the influence of habitual short sleep duration on EPC 
number and function. It is important to note, however, 
that we studied healthy individuals without co-existing 
cardiovascular risk factors. Considering obesity, type-2 
diabetes, and the metabolic syndrome, common morbidities 
in middle-aged adults are associated with both short 
sleep duration[1] and EPC dysfunction;[11,16] the presence 
of these and other risk factors may alter our results. 
Nevertheless, these data suggest that numerical and 
functional impairment in EPCs, independent of other risk 
factors do not contribute to the increased cardiovascular 
risk associated with habitual short sleep duration.
Although there is currently no clear consensus on the 
most appropriate criteria for the isolation, culture or 
quantification of EPCs, in the present study we isolated 
and identified a putative EPC cell population that has been 
consistently shown to participate in vasculogenesis and 
vascular repair,[17] and is associated with both endothelial 
dysfunction and cardiovascular risk.[8] These cells were 
isolated with minimal time in culture to reduce phenotypic 
drift and exhibited several endothelial phenotypic 
characteristics.[17] In contrast, other investigators have 
argued that “outgrowth endothelial cells”, a proliferative 
endothelial phenotype derived from mononuclear cells 
following an extended period of in vitro culture (2–4 weeks), 
should be considered as true endothelial progenitors, 
Table 1: Selected subject characteristics
Variable Normal Sleep 
Duration
Short Sleep 
Duration
(n=20) (n=17)
Males/Females 13/7 9/8
Age, year 59 ± 1 56 ± 2
Sleep Duration (hrs/night)  7.7 ± 0.1  6.0 ± 0.2*
Body mass, kg 86.4 ± 3.6 85.4 ± 3.8
BMI, kg/m2 28.7 ± 1.0 29.1 ± 0.9
Body fat, % 32.9 ± 1.9 36.1 ± 1.9
Waist circumference, cm 97.8 ± 2.8 95.3 ± 3.5
Waist-to-hip ratio   0.90 ± 0.05 0.89 ± 0.03
Systolic BP, mmHg 125 ± 2 123 ± 2
Diastolic BP, mmHg 77 ± 1 79 ± 1
Total cholesterol, mmol/L  5.0 ± 0.3  5.3 ± 0.2
LDL-cholesterol, mmol/L  3.1 ± 0.2  3.4 ± 0.1
HDL-cholesterol, mmol/L  1.3 ± 0.1  1.4 ± 0.1
Triglycerides, mmol/L  1.3 ± 0.1  1.2 ± 0.1  
Glucose, mmol/L  5.0 ± 0.3  5.0 ± 0.1
Insulin, pmol/L 26.4 ± 6.3 33.9 ± 6.9
HOMA-IR  1.1 ± 0.3 1.3 ± 0.3
Values are mean±SEM. BMI: Body mass index; BP: Blood pressure; LDL: Low-
density lipoprotein; HDL: High-density lipoprotein; HOMA-IR: Homeostasis model 
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given their morphological similarity to mature endothelial 
cells.[18] However, the culture of these cells involves 
untold phenotypic drift from the cells in circulation and 
their physiological and clinical relevance are unclear. 
Nevertheless, our results must be viewed within the context 
of our isolation, culture, and characterization methodology.
In conclusion, short sleep duration is not associated with 
impairment in either EPC number or function in otherwise 
healthy adults. Although recent data implicate endothelial 
damage and dysfunction as potential mechanisms 
underlying the increased cardiovascular risk associated 
with chronic short sleep duration, our results indicate that 
deficits in EPC number and function are not apparent 
in healthy individuals who sleep between four and seven 
hours per night. Future research is necessary to determine 
if more severe chronic sleep restriction is associated with 
impairment of endothelial repair processes.
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